Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degraders

Jayapal Reddy Mallareddy, Lin Yang, Wan Hsin Lin, Ryan Feathers, Jennifer Ayers-Ringler, Ezequiel Tolosa, Amritha G. Kizhake, Smitha Kizhake, Sydney P. Kubica, Lidia Boghean, Sophie Alvarez, Michael J. Naldrett, Sarbjit Singh, Sandeep Rana, Muhammad Zahid, Janet Schaefer-Klein, Anja Roden, Farhad Kosari, Panos Z. Anastasiadis, Mitesh BoradAmarnath Natarajan, Aaron S. Mansfield

Research output: Contribution to journalArticlepeer-review

Abstract

Despite ongoing efforts to employ structure-based methods to discover targeted protein degraders (TPD), the prevailing strategy continues to be the synthesis of a focused set of heterobifunctional compounds and screening them for target protein degradation. Here we used a fluorescence based live cell imaging screen to identify degraders that target exon 14 skipped hepatocyte growth factor receptor (MET). MET is a known oncogenic driver. MET exon 14 skipping mutations (METex14Δ) are found in lung cancers and result in the loss of a degron that is required for E3-ligase recognition and subsequent ubiquitination, prolonging the half-life and oncogenicity of MET. Since proteolysis targeting chimeras (PROTACs) are heterobifunctional molecules that promote target degradation by the proteosome, we sought to restore degradation of MET lost with METex14Δ using a MET-targeting PROTAC. We generated a library of sixty PROTACs of which 37 used the MET inhibitor capmatinib as the protein of interest targeting ligand. We screened this PROTAC library for targeted degradation of METex14Δ-GFP using live cell imaging. We benchmarked the MET-targeting PROTACs to that of a previously reported MET-targeting PROTAC, SJF8240. Curve fitting live cell imaging data affords determination of time required to degrade 50% of the target protein (DT50), which was used in determining structure activity relationships. A promising candidate, 48-284, identified from the screen, exhibited classic PROTAC characteristics, was >15-fold more potent than SJF8240, had fewer off targets compared to SJF8240, and degraded MET in multiple cell lines.

Original languageEnglish (US)
Pages (from-to)10419-10425
Number of pages7
JournalRSC Advances
Volume15
Issue number13
DOIs
StatePublished - Apr 3 2025

ASJC Scopus subject areas

  • General Chemistry
  • General Chemical Engineering

Fingerprint

Dive into the research topics of 'Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degraders'. Together they form a unique fingerprint.

Cite this